arrow
A

Akshita Gupta

Bristol Myers Squibb
H指数:11
被引数:630

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A comprehensive longitudinal analysis of the cellular immune response specific to the spike protein in healthcare workers vaccinated against SARS-CoV-2– ORCHESTRA Project

针对接种SARS-CoV-2疫苗的医疗保健工作者中针对刺突蛋白的细胞免疫反应的全面纵向分析——ORCHESTRA项目

2025-11-250
OAAI
Rationale and feasibility of a rapid integral biomarker program that informs immune-oncology clinical trials: the ADVISE trial

快速整合生物标志物计划在指导免疫肿瘤临床试验中的合理性与可行性:ADVISE试验

2025-05-190
OA
Chemosensory assessment and impact on quality of life in neurosensorial cluster of the post COVID 19 syndrome
2024-09-090
OAAI
Interleukin-2-mediated CD4 T-cell activation correlates highly with effective serological and T-cell responses to SARS-CoV-2 vaccination in people living with HIV
2024-07-261
OAAI
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort

使用机器学习预测实体器官移植受者对SARS-CoV-2疫苗的抗体反应: 多中心ORCHESTRA队列

2023-08-016
OAAI
Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments

宿主免疫反应促进接受单克隆抗体治疗的患者发生SARS-CoV-2突变

2023-03-1521
OAAI
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors

基于血液细胞因子和生长因子的肿瘤患者BNT162b2疫苗应答预测模型

2022-12-221
OAAI
Clinical Impact of Monoclonal Antibodies in the Treatment of High-Risk Patients with SARS-CoV-2 Breakthrough Infections: The ORCHESTRA Prospective Cohort Study

单克隆抗体治疗SARS-CoV-2突破性感染高危患者的临床影响: ORCHESTRA前瞻性队列研究

2022-08-242
OAAI